First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation

Abstract

The use of the Claret CE Pro™ system is feasible and safe. Capture of debris in more than half of the patients provides evidence for the potential to reduce the procedural cerebral embolic burden utilising this dedicated filter system during TAVI.